Reg Pulse blog

Reg Pulse promotes the sharing of insights, experiences and perspectives on the latest regulatory developments and trends.  


Can hospital CFOs square their medical necessity risks with revenue goals?

Balancing act

There’s a lot of push-and-pull these days between hospitals and federal regulators regarding what’s medically necessary—and therefore, what’s reimbursable by Medicare. With medical necessity, particularly for short-stay admissions under scrutiny by Medicare, hospitals are not only attempting to better understand and anticipate what Medicare is likely to reimburse, they’re also trying to pick the right focus areas when it comes to appealing Medicare denials.

Patient criteria

Many hospitals are trying to better understand the criteria for inpatient or outpatient placement and when the criteria is actually applied in order to help deliver the highest standard of care. Although the balancing act between quality of care and management of costs is not a new challenge for hospitals, the issue of medical necessity has raised the stakes for getting it right.

Back to top

Compliance and revenue protection

Download PDF

Gain insight into tough questions CFOs and their teams should be answering.

If CFOs want to reduce revenue losses and compliance challenges associated with medical necessity missteps, they should start getting answers to tougher questions covering a range of issues. In this paper, we’ve outlined five core areas where CFOs should consider focusing on:

  • Redefine the role of case managers
  • Use existing data to establish the baseline
  • Focus on measuring and monitoring
  • Create a document trail and have a defensible process
  • Be more selective about appeals


Back to top

Meet the leader

Kelly Sauders

Kelly Sauders

Partner |Life Sciences & Health Care

A Partner at Deloitte & Touche LLP, Kelly provides...More

Contact us

Contact us via our online form

Submit RFP

Submit via our online form

Find an office

Find a local office


Center for Regulatory Strategies

The Deloitte Center for Regulatory Strategies provides deep knowledge and practical insight into regulatory matters across heavily regulated industries. 


Governance, Regulatory, and Risk Strategies

Deloitte can help you create and protect value and enhance effective management of governance, regulatory and compliance risks on a sustained basis.


Kevin McGovern

Managing Partner | Governance, Regulatory & Risk


George Serafin

Managing Director | Life Sciences & Healthcare


Tom Rollauer

Director | Center for Regulatory Strategies